The association between L:M cone ratio, cone opsin genes and myopia susceptibility.


Journal

Vision research
ISSN: 1878-5646
Titre abrégé: Vision Res
Pays: England
ID NLM: 0417402

Informations de publication

Date de publication:
09 2019
Historique:
received: 10 04 2019
revised: 12 06 2019
accepted: 13 06 2019
pubmed: 30 6 2019
medline: 23 5 2020
entrez: 30 6 2019
Statut: ppublish

Résumé

In syndromic forms of myopia caused by long (L) to middle (M) wavelength (L/M) interchange mutations, erroneous contrast signals from ON-bipolar cells activated by cones with different levels of opsin expression are suggested to make the eye susceptible to increased growth. This susceptibility is modulated by the L:M cone ratio. Here, we examined L and M opsin genes, L:M cone ratios and their association with common refractive errors in a population with low myopia prevalence. Cycloplegic autorefraction and ocular biometry were obtained for Norwegian genetically-confirmed normal trichromats. L:M cone ratios were estimated from spectral sensitivity functions measured with full-field ERG, after adjusting for individual differences in the wavelength of peak absorption deduced from cone opsin genetics. Mean L:M cone ratios and the frequency of alanine at L opsin position 180 were higher in males than what has been reported in males in populations with high myopia prevalence. High L:M cone ratios in females were associated with lower degree of myopia, and myopia was more frequent in females who were heterozygous for L opsin exon 3 haplotypes than in those who were homozygous. The results suggest that the L:M cone ratio, combined with milder versions of L opsin gene polymorphisms, may play a role in common myopia. This may in part explain the low myopia prevalence in Norwegian adolescents and why myopia prevalence was higher in females who were heterozygous for the L opsin exon 3 haplotype, since females are twice as likely to have genetic polymorphisms carried on the X-chromosome.

Identifiants

pubmed: 31254532
pii: S0042-6989(19)30127-0
doi: 10.1016/j.visres.2019.06.006
pmc: PMC7122956
mid: NIHMS1554499
pii:
doi:

Substances chimiques

Cone Opsins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-28

Subventions

Organisme : NEI NIH HHS
ID : P30 EY001730
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY028118
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Vision Res. 1998 Jun;38(13):1961-6
pubmed: 9797942
Neuron. 2004 Aug 19;43(4):447-68
pubmed: 15312645
Br J Ophthalmol. 2016 Jul;100(7):882-890
pubmed: 26802174
Ophthalmology. 2016 May;123(5):1036-42
pubmed: 26875007
Optom Vis Sci. 2015 Mar;92(3):258-66
pubmed: 25611765
Vision Res. 2002 May;42(11):1367-78
pubmed: 12044743
Transl Vis Sci Technol. 2017 May 10;6(3):2
pubmed: 28516000
J Opt Soc Am A Opt Image Sci Vis. 1996 Mar;13(3):641-8
pubmed: 8627421
Vision Res. 1982;22(6):635-43
pubmed: 6981244
Proc Biol Sci. 1996 May 22;263(1370):593-9
pubmed: 8677259
J Opt Soc Am A Opt Image Sci Vis. 2014 Apr 1;31(4):A401-9
pubmed: 24695200
J Opt Soc Am A. 1987 Oct;4(10):1992-2005
pubmed: 3430210
J Opt Soc Am. 1960 Apr;50:341-2
pubmed: 13844641
Jpn J Ophthalmol. 2001 Jan-Feb;45(1):60-7
pubmed: 11163047
Sci Rep. 2016 Jun 24;6:28253
pubmed: 27339364
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):4856-4870
pubmed: 30347082
Arch Ophthalmol. 1993 Jun;111(6):831-6
pubmed: 8512486
Vis Neurosci. 2008 May-Jun;25(3):501-5
pubmed: 18598425
Vision Res. 2012 Nov 15;73:1-9
pubmed: 23022137
J Opt Soc Am A Opt Image Sci Vis. 2000 Mar;17(3):499-509
pubmed: 10708031
J Opt Soc Am A Opt Image Sci Vis. 1998 Jan;15(1):16-22
pubmed: 9459792
Exp Eye Res. 2018 Jul;172:104-111
pubmed: 29608907
Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1598-605
pubmed: 19098322
Hum Mol Genet. 1993 Sep;2(9):1413-21
pubmed: 8242064
J Neurosci. 2005 Oct 19;25(42):9669-79
pubmed: 16237171
Invest Ophthalmol Vis Sci. 2013 Feb 15;54(2):1361-9
pubmed: 23322568
Am J Hum Genet. 1992 Aug;51(2):291-8
pubmed: 1642230
Hum Genet. 1995 May;95(5):501-6
pubmed: 7759069
Vision Res. 2006 Oct;46(19):3079-89
pubmed: 16782165
Vision Res. 2011 Apr 13;51(7):633-51
pubmed: 21167193
Vision Res. 2015 Nov;116(Pt A):13-24
pubmed: 26368273
BMJ. 2018 Jun 6;361:k2022
pubmed: 29875094
Br J Ophthalmol. 2008 Nov;92(11):1471-5
pubmed: 18586899
Vision Res. 2008 Sep;48(20):2042-51
pubmed: 18627773
Optom Vis Sci. 2015 Jan;92(1):e1-5
pubmed: 25379632
Nature. 1992 Apr 2;356(6368):431-3
pubmed: 1557123
Ann Acad Med Singap. 2004 Jan;33(1):27-33
pubmed: 15008558
J Vis. 2002;2(8):531-42
pubmed: 12678637
Ophthalmology. 2018 Aug;125(8):1239-1250
pubmed: 29371008
Vis Neurosci. 2008 Sep-Dec;25(5-6):619-33
pubmed: 18983718
PLoS One. 2016 Jan 19;11(1):e0146332
pubmed: 26783753
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4238-4248
pubmed: 30128495
Vis Neurosci. 2004 May-Jun;21(3):477-82
pubmed: 15518233
Vision Res. 2001;41(10-11):1291-306
pubmed: 11322974
Acta Ophthalmol (Copenh). 1968;46(1):33-40
pubmed: 5300920
J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):484-6
pubmed: 25709775
J Vis. 2006 Mar 21;6(3):285-302
pubmed: 16643096
Biol Lett. 2017 Mar;13(3):
pubmed: 28275167
Sci Rep. 2018 Sep 7;8(1):13479
pubmed: 30194363
Appl Opt. 1987 Apr 15;26(8):1437-40
pubmed: 20454339
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1834-1842
pubmed: 28358949
Biol Rev Camb Philos Soc. 1972 Jan;47(1):1-35
pubmed: 4554151
Behav Genet. 1996 May;26(3):195-207
pubmed: 8754247
Transl Vis Sci Technol. 2016 Sep 6;5(5):2
pubmed: 27622081
J Refract Surg. 2004 Sep-Oct;20(5):S508-14
pubmed: 15523967
Invest Ophthalmol Vis Sci. 2012 Dec 05;53(13):8006-15
pubmed: 23139274
Neuron. 1994 May;12(5):1131-8
pubmed: 8185948
Ophthalmic Physiol Opt. 2012 Jan;32(1):3-16
pubmed: 22150586
J Vis. 2008 Feb 20;8(2):5.1-9
pubmed: 18318631
Nat Neurosci. 1999 Oct;2(10):884-8
pubmed: 10491608
Nat Neurosci. 2011 Sep 18;14(10):1309-16
pubmed: 21926983
Vision Res. 2019 Sep;162:20-28
pubmed: 31254532
Hum Genet. 2000 Oct;107(4):343-9
pubmed: 11129333
Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):2142-2152
pubmed: 29801149
Science. 1991 May 17;252(5008):971-4
pubmed: 1903559

Auteurs

Lene A Hagen (LA)

National Centre for Optics, Vision and Eye Care, Faculty of Health and Social Sciences, University of South-Eastern Norway, Hasbergs vei 36, 3616 Kongsberg, Norway. Electronic address: lene.hagen@usn.no.

Solveig Arnegard (S)

National Centre for Optics, Vision and Eye Care, Faculty of Health and Social Sciences, University of South-Eastern Norway, Hasbergs vei 36, 3616 Kongsberg, Norway. Electronic address: solveig.arnegard@icloud.com.

James A Kuchenbecker (JA)

Department of Ophthalmology, University of Washington Medical School, Box 358058, 750 Republican Street, Building E Room, Seattle, WA 98109, United States.

Stuart J Gilson (SJ)

National Centre for Optics, Vision and Eye Care, Faculty of Health and Social Sciences, University of South-Eastern Norway, Hasbergs vei 36, 3616 Kongsberg, Norway. Electronic address: stuart.j.gilson@usn.no.

Maureen Neitz (M)

Department of Ophthalmology, University of Washington Medical School, Box 358058, 750 Republican Street, Building E Room, Seattle, WA 98109, United States. Electronic address: mneitz@uw.edu.

Jay Neitz (J)

Department of Ophthalmology, University of Washington Medical School, Box 358058, 750 Republican Street, Building E Room, Seattle, WA 98109, United States. Electronic address: jneitz@uw.edu.

Rigmor C Baraas (RC)

National Centre for Optics, Vision and Eye Care, Faculty of Health and Social Sciences, University of South-Eastern Norway, Hasbergs vei 36, 3616 Kongsberg, Norway. Electronic address: rigmor.baraas@usn.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH